☆ 4.5 Article

Effect of Clemastine on Neurophysiological Outcomes in an Ovine Model of Neonatal Hypoxic-Ischemic Encephalopathy

CHILDREN-BASEL (2023)

Related references

Note: Only part of the references are listed.

Article Multidisciplinary Sciences

Comparing the efficacy in reducing brain injury of different neuroprotective agents following neonatal hypoxia-ischemia in newborn rats: a multi-drug randomized controlled screening trial

Hemmen Sabir et al.

Summary: Intrapartum hypoxia-ischemia leading to neonatal encephalopathy is a major cause of neonatal mortality and morbidity worldwide, particularly in low- and middle-income countries. Therapeutic hypothermia is currently the only effective treatment available in high-income countries, but its effectiveness is limited in LMIC. In this study, we compared the effects of 25 potential neuroprotective drug candidates on neonatal hypoxic-ischemic brain injury in rats. We found that caffeine, Sonic Hedgehog Agonist (SAG), and Allopurinol had the strongest treatment effects, followed by Melatonin, Clemastine, ss-Hydroxybutyrate, Omegaven, and Iodide. These alternative therapies may hold promise for the treatment of hypoxic-ischemic brain injury in LMIC.

SCIENTIFIC REPORTS (2023)

Add to Collection

Review Medicine, Research & Experimental

Drug repurposing: Clemastine fumarate and neurodegeneration

Jiahui Zhu et al.

Summary: Neurodegenerative diseases are a serious problem in older people, causing motor and cognitive defects and lowering their quality of life, necessitating effective treatment. Drug repurposing, the exploration of existing drugs for new therapeutic purposes, has become a wise and popular strategy to provide new treatment options. Clemastine fumarate, a promising drug for remyelination and autophagy enhancement, has been identified through screening. This review summarizes the potential mechanisms of clemastine fumarate in current literature and aims to find worthwhile research directions for neurodegeneration diseases by distinguishing the independent or synergistic effects between clemastine and fumarate.

BIOMEDICINE & PHARMACOTHERAPY (2023)

Add to Collection

Article Neurosciences

Hypoxic oligodendrocyte precursor cell-derived VEGFA is associated with blood-brain barrier impairment

Narek Manukjan et al.

Summary: Cerebral small vessel disease is characterized by decreased cerebral blood flow and blood-brain barrier impairments, leading to the development of white matter lesions. Cerebral hypoperfusion induces hypoxia and affects the signaling between oligodendrocyte precursor cells and endothelial cells, resulting in blood-brain barrier dysfunction. In this study, a mouse model of cerebral hypoperfusion was used to investigate the role of hypoxia-induced VEGFA expression in the development of white matter lesions. The results suggest that VEGFA upregulation in hypoxic oligodendrocyte precursor cells mediates blood-brain barrier permeability, which is associated with increased VEGFA plasma levels in cerebral small vessel disease patients.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2023)

Add to Collection

Article Clinical Neurology

Increased Systemic Immune-Inflammation Index Predicts Disease Severity and Functional Outcome in Acute Ischemic Stroke Patients

Lu Huang

Summary: This study aimed to investigate the relationship between systemic immune-inflammation index (SII) and system inflammation response index (SIRI) and severity of stroke, and to analyze their prognostic value in acute ischemic stroke (AIS) patients. The results showed that higher SII and SIRI indexes were associated with greater risk of stroke severity, while SII could be useful for predicting adverse clinical outcomes after AIS.

NEUROLOGIST (2023)

Add to Collection

Review Pharmacology & Pharmacy

Antihistamine use during breastfeeding with focus on breast milk transfer and safety in humans: A systematic literature review

Elin Ngo et al.

Summary: Current data on the use of antihistamines during breastfeeding and risks to the breastfed infants are insufficient, further human studies are needed; most product labels recommend avoiding the use of antihistamines during breastfeeding.

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Clemastine Enhances Myelination, Delays Axonal Loss and Promotes Functional Recovery in Spinal Cord Injury

Weihong Du et al.

Summary: Recent evidence suggests that demyelination and axonal degeneration occur in spinal cord injury during the secondary injury phase. Treatment with clemastine, an FDA-approved drug, was shown to preserve myelin integrity, decrease axonal loss, and improve functional recovery in a rat SCI model. This indicates that myelination-enhancing strategies could potentially be a therapeutic approach for functional recovery in SCI.

NEUROCHEMICAL RESEARCH (2022)

Add to Collection

Article Clinical Neurology

Prognostic impact of blood urea nitrogen/creatinine ratio changes in patients with acute ischemic stroke

Wei-Feng Jiang et al.

Summary: This study investigated the association between changes in BUN/Cr and stroke outcomes during hospitalization after acute ischemic stroke (AIS). The results demonstrated that the decrease in BUN/Cr is positively correlated with better early neurological improvement in AIS patients.

CLINICAL NEUROLOGY AND NEUROSURGERY (2022)

Add to Collection

Article Developmental Biology

Defining Longer-Term Outcomes in an Ovine Model of Moderate Perinatal Hypoxia-Ischemia

Jana Krystofova Mike et al.

Summary: Hypoxic-ischemic encephalopathy (HIE) is a major cause of neonatal morbidity and mortality worldwide. The outcomes of moderate HIE are highly unpredictable, making therapeutic approaches challenging.

DEVELOPMENTAL NEUROSCIENCE (2022)

Add to Collection

Article Clinical Neurology

Immunocytes Rapid Responses Post-ischemic Stroke in Peripheral Blood in Patients With Different Ages

Haiyue Zhang et al.

Summary: This study investigated the changes in immune cell composition in the peripheral blood of patients with acute ischemic stroke (AIS) based on their age groups. The results showed that the proportions of certain immune cells differed among the age groups, with a decrease in certain cells as age increased. These differences may have implications for clinical outcomes and suggest the need for customized treatment for AIS in different age groups.

FRONTIERS IN NEUROLOGY (2022)

Add to Collection

Article Cell Biology

Clemastine Induces an Impairment in Developmental Myelination

Ana Palma et al.

Summary: Abnormalities in myelination are associated with behavioral and cognitive dysfunction in neurodevelopmental psychiatric disorders. Clemastine, a drug that promotes myelination, has complex effects on myelin development during the developmental process. The study found that clemastine treatment increased oligodendrocyte differentiation but decreased conduction velocity and myelin thickness in the corpus callosum. Additionally, the population of microglia cells and insulin growth factor-1 levels decreased in clemastine-treated mice.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Add to Collection

Article Pharmacology & Pharmacy

Clemastine Promotes Differentiation of Oligodendrocyte Progenitor Cells Through the Activation of ERK1/2 via Muscarinic Receptors After Spinal Cord Injury

Lu-Yao Tong et al.

Summary: The recovery of spinal cord injury is hindered by the obstruction of oligodendrocyte progenitor cell differentiation. Drug-based methods, such as clemastine treatment, have been found to promote OPC differentiation and improve functional recovery in the SCI model. This study investigates the effects of clemastine on OPC differentiation through MRs and the underlying mechanism.

FRONTIERS IN PHARMACOLOGY (2022)

Add to Collection

Review Psychiatry

Histamine and histamine receptors: Roles in major depressive disorder

Hong Qian et al.

Summary: This article explores the impact of the histaminergic system on depression, highlighting the involvement of histamine and its receptors in the occurrence and immune regulation of depression. The findings suggest that histamine receptors can be potential targets for the development of new antidepressant drugs.

FRONTIERS IN PSYCHIATRY (2022)

Add to Collection

Article Pediatrics

Study on the relationship between nephrotic syndrome and atopic diseases in childhood

Yue Zheng et al.

Summary: The present study found a high co-morbidity between nephrotic syndrome and atopic diseases in children. Allergy-related factors might be an important recurrence factor in children with nephrotic syndrome. The injury to the filtration barrier in minimal change disease (MCD) might not only be correlated with podocyte lesions but also with some serum permeability factors, such as serum IgE, histamine, and bradykinin.

FRONTIERS IN PEDIATRICS (2022)

Add to Collection

Article Pediatrics

Cardiovascular management following hypoxic-ischemic encephalopathy in North America: need for physiologic consideration

Regan E. Giesinger et al.

Summary: Cardiovascular practices in neonates with HIE differ between centers with and without TnECHO, highlighting the lack of consensus regarding the definition of hypotension and the common use of dopamine. Enhanced cardiovascular care guided by hemodynamic specialists requires prospective evaluation to improve outcomes for these patients.

PEDIATRIC RESEARCH (2021)

Add to Collection

Article Immunology

Neutrophil dynamics, plasticity and function in acute neurodegeneration following neonatal hypoxia-ischemia

Kerstin Muelling et al.

Summary: This study found that neutrophils in the neonatal brain are rapidly activated after experimental hypoxia-ischemia, producing reactive oxygen species and showing an increased proportion of hyperactivated/aged cells compared to peripheral neutrophils. Delayed neutrophil depletion led to reduced cellular neurodegeneration and decreased microglial and astroglial activation, offering new possibilities for therapeutic approaches in post-hypoxic brain injury.

BRAIN BEHAVIOR AND IMMUNITY (2021)

Add to Collection

Article Clinical Neurology

Increased Systemic Immune-Inflammation Index Is Associated With Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage Patients

Liuwei Chen et al.

Summary: SII is an independent predictor of delayed cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage, and can be implemented in a routine clinical setting to help diagnose patients with high risk of DCI.

FRONTIERS IN NEUROLOGY (2021)

Add to Collection

Article Cell Biology

Clemastine Ameliorates Myelin Deficits via Preventing Senescence of Oligodendrocytes Precursor Cells in Alzheimer's Disease Model Mouse

Yuan-Yuan Xie et al.

Summary: Clemastine, an H1-antihistamine, has the potential to induce OPC differentiation and myelin formation under different neuropathological conditions. In aged APPSwe/PS1dE9 mice, chronic clemastine treatment reduced brain amyloid-beta deposition, improved short-term memory deficit, enhanced OPC density, and prevented OPCs from entering cellular senescence, showing therapeutic potential in Alzheimer's disease.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Add to Collection

Article Neuroimaging

Myelination may be impaired in neonates following birth asphyxia

Bianca Olivieri et al.

Summary: This study aimed to assess the myelination pattern in neonates with neonatal encephalopathy (NE) who developed brain injury compared to those without injury over the first month of life. The results showed that in NE neonates treated with hypothermia who developed brain injury, birth asphyxia impaired myelination in various brain regions, indicating a potential link between birth asphyxia and myelination deficits.

NEUROIMAGE-CLINICAL (2021)

Add to Collection

Article Critical Care Medicine

Early cytotoxic lymphocyte localization to the brain following resuscitation in a porcine model of asphyxial cardiac arrest: A pilot study

Tanner Smida et al.

Summary: The preliminary study suggests that cytotoxic lymphocytes may be localizing to the brain during cardiac arrest resuscitation.

RESUSCITATION PLUS (2021)

Add to Collection

Article Medicine, General & Internal

Clemastine promotes recovery of neural function and suppresses neuronal apoptosis by restoring balance of pro-inflammatory mediators in an experimental model of intracerebral hemorrhage

Cheng Zhi et al.

Summary: The study found that CLM had positive effects on ICH, including reducing intracerebral hematoma, cerebral edema, neuronal apoptosis rates, and improving behavioral scores. CLM treatment reduced the levels of pro-inflammatory factors and increased the expression of anti-inflammatory factors. CLM may enhance neuronal function restoration by inhibiting microglia-induced inflammatory response and apoptosis.

INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2021)

Add to Collection

Article Immunology

Clemastine improves hypomyelination in rats with hypoxic-ischemic brain injury by reducing microglia-derived IL-1β via P38 signaling pathway

Di Xie et al.

JOURNAL OF NEUROINFLAMMATION (2020)

Add to Collection

Review Allergy

Antihistamines in children and adolescents: A practical update

G. F. Parisi et al.

ALLERGOLOGIA ET IMMUNOPATHOLOGIA (2020)

Add to Collection

Article Medicine, Research & Experimental

Identifying the pattern of immune related cells and genes in the peripheral blood of ischemic stroke

Zijian Li et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2020)

Add to Collection

Article Multidisciplinary Sciences

The correlation between novel peripheral blood cell ratios and 90-day mortality in patients with acute ischemic stroke

Xiaofeng Cao et al.

PLOS ONE (2020)

Add to Collection

Article Pharmacology & Pharmacy

Torsadogenic potential of a novel remyelinating drug clemastine for multiple sclerosis assessed in the rabbit proarrhythmia model

Satoshi Kawakami et al.

JOURNAL OF PHARMACOLOGICAL SCIENCES (2020)

Add to Collection

Review Genetics & Heredity

Insight into the mechanism of action of dimethyl fumarate in multiple sclerosis

Sudhir Kumar Yadav et al.

JOURNAL OF MOLECULAR MEDICINE-JMM (2019)

Add to Collection

Review Biochemistry & Molecular Biology

Crazy Little Thing Called SoxNew Insights in Oligodendroglial Sox Protein Function

Jan Wittstatt et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Add to Collection

Review Allergy

CSACI position statement: Newer generation H1-antihistamines are safer than first-generation H1-antihistamines and should be the first-line antihistamines for the treatment of allergic rhinitis and urticaria

Michael N. Fein et al.

ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY (2019)

Add to Collection

Review Pharmacology & Pharmacy

Dimethyl Fumarate: A Review in Relapsing-Remitting MS

Hannah A. Blair

DRUGS (2019)

Add to Collection

Review Physiology

Gender Differences Involved in the Pathophysiology of the Perinatal Hypoxic-Ischemic Damage

S. Murden et al.

PHYSIOLOGICAL RESEARCH (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Neuroprotective effect of licochalcone A against oxygen-glucose deprivation/reperfusion in rat primary cortical neurons by attenuating oxidative stress injury and inflammatory response via the SIRT1/Nrf2 pathway

Xiaohong Liu et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2018)

Add to Collection

Review Neurosciences

Allosteric modulators targeting CNS muscarinic receptors

Andreas Bock et al.

NEUROPHARMACOLOGY (2018)

Add to Collection

Article Neurosciences

Enhancing Oligodendrocyte Myelination Rescues Synaptic Loss and Improves Functional Recovery after Chronic Hypoxia

Fei Wang et al.

NEURON (2018)

Add to Collection

Article Immunology

Peripheral T Cell Depletion by FTY720 Exacerbates Hypoxic-Ischemic Brain Injury in Neonatal Mice

Josephine Herz et al.

FRONTIERS IN IMMUNOLOGY (2018)

Add to Collection

Article Neurosciences

Clemastine Alleviates Depressive-Like Behavior Through Reversing the Imbalance of Microglia-Related Pro-inflammatory State in Mouse Hippocampus

Wen-Jun Su et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2018)

Add to Collection

Article Clinical Neurology

Clemastine rescues myelination defects and promotes functional recovery in hypoxic brain injury

Bruce A. C. Cree et al.

BRAIN (2018)

Add to Collection

Article Medicine, General & Internal

Absolute lymphocyte and neutrophil counts in neonatal ischemic brain injury

Jessica M. Povroznik et al.

SAGE OPEN MEDICINE (2018)

Add to Collection

Review Clinical Neurology

Insights Into the Neuroinflammatory Responses After Neonatal Hypoxia-Ischemia

Malgorzata Ziemka-Nalecz et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2017)

Add to Collection

Article Medicine, General & Internal

Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial

Ari J. Green et al.

LANCET (2017)

Add to Collection

Article Multidisciplinary Sciences

All muscarinic acetylcholine receptors (M1-M5) are expressed in murine brain microvascular endothelium

Beatrice Mihaela Radu et al.

SCIENTIFIC REPORTS (2017)

Add to Collection

Review Clinical Neurology

Neonatal Hypoxic-ischemic Encephalopathy: A Radiological Review

Shahina Bano et al.

JOURNAL OF PEDIATRIC NEUROSCIENCES (2017)

Add to Collection

Article Obstetrics & Gynecology

Persistent systemic monocyte and neutrophil activation in neonatal encephalopathy

F. M. O'Hare et al.

JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2016)

Add to Collection

Article Oncology

Argon protects against hypoxic-ischemic brain injury in neonatal rats through activation of nuclear factor (erythroid-derived 2)-like 2

Hailin Zhao et al.

ONCOTARGET (2016)

Add to Collection

Article Immunology

Sexually dimorphic outcomes and inflammatory responses in hypoxic-ischemic encephalopathy

Mehwish A. Mirza et al.

JOURNAL OF NEUROINFLAMMATION (2015)

Add to Collection

Article Clinical Neurology

Elevated blood urea nitrogen/creatinine ratio is associated with poor outcome in patients with ischemic stroke

Jon W. Schrock et al.

CLINICAL NEUROLOGY AND NEUROSURGERY (2012)

Add to Collection

Review Neurosciences

Muscarinic Receptors: Their Roles in Disorders of the Central Nervous System and Potential as Therapeutic Targets

Elizabeth Scarr

CNS NEUROSCIENCE & THERAPEUTICS (2012)

Add to Collection

Article Developmental Biology

Muscarinic receptor subtypes as potential targets to modulate oligodendrocyte progenitor survival, proliferation, and differentiation

Federica De Angelis et al.

DEVELOPMENTAL NEUROBIOLOGY (2012)

Add to Collection

Article Clinical Neurology

Mast Cells Are Early Responders After Hypoxia-Ischemia in Immature Rat Brain

Yuxuan Jin et al.

STROKE (2009)

Add to Collection

Article Cardiac & Cardiovascular Systems

Clemastine, a conventional antihistamine, is a high potency inhibitor of the HERG K+ channel

JM Ridley et al.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2006)

Add to Collection

© Peeref 2019-2024. All rights reserved.